|
Volumn 25, Issue 4, 2007, Pages 150-154
|
Anticoagulation
|
Author keywords
anticoagulation; bleeding; heparin; thrombocytopenia; warfarin
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALLOPURINOL;
AMIODARONE;
ANTICOAGULANT AGENT;
ANTICONVULSIVE AGENT;
ANTIINFECTIVE AGENT;
ANTITHROMBOCYTIC AGENT;
BLOOD CLOTTING FACTOR 10A;
CIMETIDINE;
CIPROFLOXACIN;
CLOPIDOGREL;
CORTICOSTEROID DERIVATIVE;
DALTEPARIN;
DICLOFENAC;
DIPYRIDAMOLE;
ENOXAPARIN;
ERYTHROMYCIN;
GLYCERYL TRINITRATE;
GRISEOFULVIN;
HEPARIN;
KETOROLAC;
LOW MOLECULAR WEIGHT HEPARIN;
METRONIDAZOLE;
NONSTEROID ANTIINFLAMMATORY AGENT;
OMEPRAZOLE;
RIFAMPICIN;
THROMBIN;
THYROXINE;
UNINDEXED DRUG;
WARFARIN;
ANTICOAGULATION;
ANTIPHOSPHOLIPID SYNDROME;
ARTERY THROMBOSIS;
ARTIFICIAL EMBOLISM;
BLEEDING DISORDER;
BLOOD CLOTTING DISORDER;
BRAIN HEMORRHAGE;
CHONDRODYSPLASIA;
CONGENITAL MALFORMATION;
CONJUNCTIVAL HEMORRHAGE;
DEEP VEIN THROMBOSIS;
DRUG ABSORPTION;
DRUG ANTAGONISM;
DRUG BIOAVAILABILITY;
DRUG DOSE REDUCTION;
DRUG FATALITY;
DRUG HALF LIFE;
DRUG HYPERSENSITIVITY;
DRUG MEGADOSE;
DRUG PROTEIN BINDING;
DRUG SUBSTITUTION;
EPISTAXIS;
FETOTOXICITY;
FETUS WASTAGE;
GASTROINTESTINAL HEMORRHAGE;
HEART ATRIUM FIBRILLATION;
HEART DISEASE;
HEART VALVE;
HEMATURIA;
HEPARIN INDUCED THROMBOCYTOPENIA;
HUMAN;
LOW DRUG DOSE;
LUNG EMBOLISM;
OSTEOPOROSIS;
PATIENT ASSESSMENT;
PRIORITY JOURNAL;
REVIEW;
SIDE EFFECT;
SKIN NECROSIS;
THROMBOCYTE COUNT;
THROMBOCYTOPENIA;
THROMBOEMBOLISM;
THROMBOSIS;
TREATMENT CONTRAINDICATION;
TREATMENT DURATION;
TREATMENT INDICATION;
VENOUS THROMBOEMBOLISM;
|
EID: 34249008194
PISSN: 02639319
EISSN: None
Source Type: Journal
DOI: 10.1016/j.mpsur.2007.01.008 Document Type: Review |
Times cited : (8)
|
References (4)
|